Les Mills

Extending Weight Loss Program Helps People Who Are Overweight Keep More Weight Off, And Is Cost-Effective

ArticlePress release
Heart & Vascular Health
Current Medical News
Contributed byMaulik P. Purohit MD MPHMay 22, 2017

Extending NHS weight loss programs from one session per week for 12-weeks to one session per week for a year helped people who are overweight to lose more weight and keep it off for longer, according to a study published in The Lancet, and led by researchers from the University of Cambridge, University of Liverpool and University of Oxford.

Although upfront costs for the longer program are higher, the study estimates that offering more sessions would be cost-effective to the NHS in the long-term because it would help to prevent more people from developing diseases as a result of their weight.

"This trial provides important data that offering support to lose weight -- by referring people to a community weight loss group -- is more successful than a self-help approach, and that providing classes for longer helps people keep weight off for longer," says Professor Susan Jebb, senior author of the study, University of Oxford, UK. "Our results also show that, in the long-term, weight loss groups are cost-effective for society as a whole because they are likely to reduce future healthcare expenditure by preventing costly conditions such as diabetes and coronary heart disease."

The NHS currently refers people who are obese to 12-week long weight loss programs run by commercial groups and provides vouchers for free attendance. These are among the most commonly commissioned programs to treat obesity in the UK and the National Institute for Health and Care Excellence recommends that programs last at least 12 weeks. However, there is little evidence to suggest how long these programs should last to be most effective..

The new study involves 1267 participants with a BMI of 28 or above and compares the effectiveness of a 12-week and year-long program of free Weight Watchers sessions to one-off advice together with a self-help booklet.

After a year, those given the self-help booklet had lost 3.3kg (7lb), those referred to the 12-week program had lost 4.8 kg (11lb), and those referred to the year-long program had lost 6.8kg (15lb) on average. Two years after they began treatment, participants in all groups regained some weight but all groups were still lighter on average than at the start of treatment.. The self-help group were 2.3kg (5lb) lighter, the 12-week program were 3.0kg (7lb) lighter, while the group offered a one-year program were 4.3kg (9lb) lighter.

Compared to participants in the other groups, those in the year-long program also had significantly greater reductions in fasting blood glucose and glycosylated haemoglobin, which are important markers of the risk of developing diabetes. After a year, those on the year-long program saw their blood glucose level reduce by 0.54mmol per litre of blood (compared to reductions of 0.27mmol/litre for the 12-week group and 0.11mmol/litre for the self-help group).

The researchers also modelled the impact of the three programs over the next 25 years to predict how many people would develop different weight-related illnesses. They also estimated the impact of the programs on quality of life, the cost of providing the programs, as well as cost-savings to health services from preventing future diseases.

The 12-week program was predicted to prevent more illnesses than the self-help intervention due to greater weight loss. Over 25 years, the cost to the NHS of providing the program would be more than offset by the later savings as a result of reductions in disease, making it overall cost-saving.

Offering a year-long program was estimated to prevent an additional 1786 cases of disease (including 642 fewer cases of hypertension, 373 fewer cases of diabetes and 104 fewer cases of heart disease) for every 100,000 people, compared to the 12-week program. So, although it was more expensive upfront, the study shows that the year-long program is cost-effective over 25 years by preventing more cases of weight related illness.

"We've seen before that a 12-week program can help people lose weight, but for the first time we've shown that extending this to a full year leads to greater weight loss over a longer period and a lower risk of diabetes," says lead author Dr Amy Ahern, MRC Epidemiology Unit at The University of Cambridge, UK. "Although the initial costs of the year-long program are greater, it's very likely that it will be good value for money over the long term because of the reduction in weight-related illnesses. The results from the one-year program are comparable to what has been seen in previous trials that used much more costly interventions, usually involving multiple contacts with health professionals." 

The researchers note some limitations within their study, including that the projections do not include potential savings in social care. Program costs may be overestimated because they assumed all participants who attended at least one session where charged at a flat rate, as opposed to a charge per session attended. In reality, the study found that those in the 12-week program attended eight of 12 sessions on average, and those on the year-long course attended 28 of 52 sessions. During the study, all participants were able to use other weight loss methods, with one in 20 people assigned to self-help attending weight loss sessions, and one in five people on the 12-week program paying to continue to take part in the program at one year.

Professor Jebb adds: "We know that many local authorities are questioning how best to spend their limited budgets. We have shown that the longer programs bring greater benefits, with only modest extra costs. But at a time when some areas are reducing their expenditure on obesity treatment, the first step is to ensure that people who want help to lose weight have access to at least a standard 12-week weight loss program, which we have shown is likely to be cost-saving for the NHS."

Writing in a linked Comment, Dr Emily Brindal, CSIRO, Australia, said: "Lifestyle programs, which target improved diet and exercise practices, reliably produce clinically relevant weight changes and are viable options that can reach multiple populations and be delivered on a large scale... the results presented by Ahern and colleagues suggest that prolonged access to active intervention might offer a simple and cost-effective method for improving weight loss outcomes in lifestyle intervention programs. This is an important finding because higher initial weight loss can improve long-term success of weight management."


Materials provided by The LancetNote: Content may be edited for style and length.

Disclaimer: DoveMed is not responsible for the accuracy of the adapted version of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Ahern, A. L., Wheeler, G. M., Aveyard, P., Boyland, E. J., Halford, J. C., Mander, A. P., ... & Mead, B. R. (2017). Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. The Lancet. DOI: 10.1016/S0140-6736(17)30647-5

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!